EUVIMEDEUVIMED entdecken
Crossref

Immunomodulatory and locomotor regulations via Diosgenin treatment in lipopolysaccharide-induced chronic fatigue syndrome (CFS)/ depressive despair symptom: an in vivo assessment

Rahul Lotan Shirole, Mohan Rajendra Khalane, Vijayeta Pralhad Nage, Nitin Lotan Shirole, Sushil Vilas Chawre, Abdulrhman Alsayari, Shadma Wahab, Adrija Bhunia, Digvijay Kailas Patil

Naunyn-Schmiedeberg's Archives of Pharmacology · 2026

DOI: 10.1007/s00210-026-05263-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2026. Verfasst von Rahul Lotan Shirole und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, DCS's A. R. A. College of Pharmacy, Dhule, Maharashtra, 424005, India. Hauptthemen laut MEDLINE: Diosgenin, Fatigue Syndrome, Chronic, Depression, Locomotion. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 65 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diosgenin is one of the several bioactive chemicals found in fenugreek. In traditional Chinese medicine and modern pharmacological studies, it is useful as anti-cancer, antiviral, anti-inflammatory, and hepatoprotective agents. However, studies investigating its role against antigen-induced neuroinflammation, providing new insights at cellular levels in its pharmacological potential, have not been completely investigated yet. Diosgenin was tested against lipopolysaccharide (LPS)-induced neuroinflammation in mice using forced swim test, tail suspension test, thermal hyperalgesia, locomotor activity, and grip strength on day 19. Brain homogenate was analyzed for estimation of reduced glutathione, superoxide dismutase (SOD), catalase (CAT), lipid peroxidation, total nitric oxide, and TNF-α levels. Pre-treatment with Diosgenin 10, 20, and 40 mg/kg, i.p. for 21 days showed a significant reduction in immobility duration and improved anxiety-like behavior. Diosgenin further reduced LPS-induced increased nitrosative and oxidative stress, evidenced by increased nitrite levels, lipid peroxidation, and reduced activity of antioxidant enzymes (CAT, SOD, and reduced glutathione), as well as amplified levels of tumor necrosis factor-α, which were associated with behavioral abnormalities. The current research indicates that Diosgenin has a protective role against LPS-induced chronic fatigue syndrome, suggesting that it could be a potent treatment option for the disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DiosgeninFatigue Syndrome, ChronicDepressionLocomotionImmunologic FactorsAnti-Inflammatory AgentsAnimalsLipopolysaccharidesMiceMaleTumor Necrosis Factor-alphaLipid PeroxidationBehavior, AnimalNitric OxideBrainOxidative StressDisease Models, Animal

Stichwörter der Autor:innen

Chronic fatigue syndromeDepressionDiosgeninExperimental pharmacologyInflammationNatural medicine

Substanzen

DiosgeninLipopolysaccharidesTumor Necrosis Factor-alphaNitric OxideImmunologic FactorsAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Department of Pharmacology, DCS's A. R. A. College of Pharmacy, Dhule, Maharashtra, 424005, India.
  • Department of Kayachikitsa, Government Ayurvedic College, Nagpur, Maharashtra, 440024, India.
  • Department of Pharmaceutical Chemistry, DCS's A. R. A. College of Pharmacy, Dhule, Maharashtra, 424005, India.
  • Department of Pharmaceutical Chemistry, N.C., Aba Patil Institute of Pharmacy, Dhule, Maharashtra, 424005, India.
  • Department of Pharmacognosy, College of Pharmacy, King Khalid University, Abha, 62529, Saudi Arabia.
  • Department of Pharmaceutics, Yenepoya Pharmacy College & Research Centre, Yenepoya (Deemed to Be University), Mangalore, Karnataka, 575018, India. adrija@yenepoya.edu.in.

Zitieren

APA

Shirole, R. L., Khalane, M. R., Nage, V. P., Shirole, N. L., Chawre, S. V., Alsayari, A., Wahab, S., Bhunia, A., & Patil, D. K. (2026). Immunomodulatory and locomotor regulations via Diosgenin treatment in lipopolysaccharide-induced chronic fatigue syndrome (CFS)/ depressive despair symptom: an in vivo assessment. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-026-05263-3

Vancouver

Shirole RL, Khalane MR, Nage VP, Shirole NL, Chawre SV, Alsayari A, et al. Immunomodulatory and locomotor regulations via Diosgenin treatment in lipopolysaccharide-induced chronic fatigue syndrome (CFS)/ depressive despair symptom: an in vivo assessment. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026. doi:10.1007/s00210-026-05263-3

BibTeX
@article{Shirole2026,
  author = {Shirole, Rahul Lotan and Khalane, Mohan Rajendra and Nage, Vijayeta Pralhad and Shirole, Nitin Lotan and Chawre, Sushil Vilas and Alsayari, Abdulrhman and Wahab, Shadma and Bhunia, Adrija and Patil, Digvijay Kailas},
  title = {Immunomodulatory and locomotor regulations via Diosgenin treatment in lipopolysaccharide-induced chronic fatigue syndrome (CFS)/ depressive despair symptom: an in vivo assessment},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2026},
  doi = {10.1007/s00210-026-05263-3}
}
Kostenlos starten →